Antonelli Alessandro, Palumbo Carlotta, Noale Marianna, Porreca Angelo, Maggi Stefania, Simeone Claudio, Bassi Pierfrancesco, Bertoni Filippo, Bracarda Sergio, Buglione Michela, Conti Giario Natale, Corvò Renzo, Gacci Mauro, Mirone Vincenzo, Montironi Rodolfo, Triggiani Luca, Tubaro Andrea, Artibani Walter
Urology Unit, ASST-Spedali Civili, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy,
Urology Unit, ASST-Spedali Civili, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.
Urol Int. 2019;103(1):8-18. doi: 10.1159/000496980. Epub 2019 Feb 7.
To report health-related quality of life outcomes as assessed by validated patient-reported outcome measures (PROMs) after radical prostatectomy (RP). -Methods: This study analyzed patients treated with RP within The PROState cancer monitoring in Italy, from the National Research Council (Pros-IT CNR). Italian versions of Short-Form Heath Survey and university of California los Angeles-prostate cancer index questionnaires were administered. PROMs were physical composite scores, mental composite scores and urinary, bowel, sexual functions and bothers (UF/B, BF/B, SF/B). Baseline unbalances were controlled with propensity scores and stabilized inverse weights; differences in PROMs between different RP approaches were estimated by mixed models.
Of 541 patients treated with RP, 115 (21%) received open RP (ORP), 90 (17%) laparoscopic RP (LRP) and 336 (61%) robot-assisted RP (RARP). At head-to-head -comparisons, RARP showed higher 12-month UF vs. LRP (interaction treatment * time p = 0.03) and 6-month SF vs. ORP (p < 0.001). At 12-month from surgery, 67, 73 and 79% of patients used no pad for urinary loss in ORP, LRP and RARP respectively (no differences for each comparison). Conversely, 16, 27 and 40% of patients declared erections firm enough for sexual intercourse in ORP, LRP and RARP respectively (only significant difference for ORP vs. RARP, p = 0.0004).
Different RP approaches lead to significant variations in urinary and sexual PROMs, with a general trend in favour of RARP. However, their clinical significance seems limited.
报告根治性前列腺切除术后通过经过验证的患者报告结局指标(PROMs)评估的健康相关生活质量结果。
本研究分析了意大利国家研究委员会(Pros-IT CNR)的前列腺癌监测项目中接受根治性前列腺切除术治疗的患者。采用了意大利语版的简明健康调查和加利福尼亚大学洛杉矶分校前列腺癌指数问卷。PROMs包括身体综合评分、心理综合评分以及泌尿、肠道、性功能和困扰(UF/B、BF/B、SF/B)。利用倾向评分和稳定的逆权重控制基线不平衡;通过混合模型估计不同根治性前列腺切除方法之间PROMs的差异。
在541例接受根治性前列腺切除术的患者中,115例(21%)接受开放性根治性前列腺切除术(ORP),90例(17%)接受腹腔镜根治性前列腺切除术(LRP),336例(61%)接受机器人辅助根治性前列腺切除术(RARP)。在直接比较中,RARP显示12个月时的UF高于LRP(交互作用治疗*时间p = 0.03),6个月时的SF高于ORP(p < 0.001)。术后12个月时,ORP、LRP和RARP分别有67%、73%和79%的患者无需使用尿垫控制尿失禁(各比较无差异)。相反,ORP、LRP和RARP分别有16%、27%和40%的患者宣称勃起硬度足以进行性交(仅ORP与RARP之间差异有统计学意义,p = 0.0004)。
不同的根治性前列腺切除方法导致泌尿和性方面的PROMs有显著差异,总体趋势有利于RARP。然而,它们的临床意义似乎有限。